Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on – FierceBiotech
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on FierceBiotech Source link
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on FierceBiotech Source link
Outgoing NIAID vaccine R&D chief John Mascola reflects on leading 'NASA-type incubator' FierceBiotech Source link
Path cleared for Iovance's lead melanoma drug after FDA assay feedback FierceBiotech Source link
Insilico Medicine's AI zeroes in on new drug targets for aging, age-related diseases FierceBiotech Source link
Eiger eager to send COVID-19 drug to FDA after hospitalizations, deaths slashed—including against omicron FierceBiotech Source link
M | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | 2 | 3 | ||||
4 | 5 | 6 | 7 | 8 | 9 | 10 |
11 | 12 | 13 | 14 | 15 | 16 | 17 |
18 | 19 | 20 | 21 | 22 | 23 | 24 |
25 | 26 | 27 | 28 | 29 | 30 |
© 2021 Nutrition Center.
© 2021 Nutrition Center.